Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0003 Transporter Info | ||||
| Gene Name | ABCB1 | ||||
| Transporter Name | P-glycoprotein 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Glycyrrhizin (high concentration) | ||||
| Xenobiotic Type | Drug in Phase 3 Trial | ||||
| MOA | Inhibition | ||||
| PubChem CID | 14982 | ||||
| Docking Score | -14.229 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C42H62O16 | ||||
| Molecular Weight | 822.9 | ||||
| Canonical SMILES |
C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)C)(C)C(=O)O
|
||||
| InChI |
InChI=1S/C42H62O16/c1-37(2)21-8-11-42(7)31(20(43)16-18-19-17-39(4,36(53)54)13-12-38(19,3)14-15-41(18,42)6)40(21,5)10-9-22(37)55-35-30(26(47)25(46)29(57-35)33(51)52)58-34-27(48)23(44)24(45)28(56-34)32(49)50/h16,19,21-31,34-35,44-48H,8-15,17H2,1-7H3,(H,49,50)(H,51,52)(H,53,54)/t19-,21-,22-,23-,24-,25-,26-,27+,28-,29-,30+,31+,34-,35-,38+,39-,40-,41+,42+/m0/s1
|
||||
| InChIKey | LPLVUJXQOOQHMX-QWBHMCJMSA-N | ||||
| Pharmaceutical Properties | Xlogp | 3.7 | Rotatable Bond Count | 7 | |
| Hydrogen Bond Donor Count | 8 | Hydrogen Bond Acceptor Count | 16 | ||
| Xenobiotic Name | Telithromycin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 3002190 | ||||
| Docking Score | -14.002 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C43H65N5O10 | ||||
| Molecular Weight | 812 | ||||
| Canonical SMILES |
CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
|
||||
| InChI |
InChI=1S/C43H65N5O10/c1-12-33-43(8)37(48(41(53)58-43)19-14-13-18-47-23-31(45-24-47)30-16-15-17-44-22-30)27(4)34(49)25(2)21-42(7,54-11)38(28(5)35(50)29(6)39(52)56-33)57-40-36(51)32(46(9)10)20-26(3)55-40/h15-17,22-29,32-33,36-38,40,51H,12-14,18-21H2,1-11H3/t25-,26-,27+,28+,29-,32+,33-,36-,37-,38-,40+,42-,43-/m1/s1
|
||||
| InChIKey | LJVAJPDWBABPEJ-PNUFFHFMSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.2 | Rotatable Bond Count | 11 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 13 | ||
| Xenobiotic Name | Paclitaxel Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 36314 | ||||
| Docking Score | -13.913 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C47H51NO14 | ||||
| Molecular Weight | 853.9 | ||||
| Canonical SMILES |
CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
|
||||
| InChI |
InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1
|
||||
| InChIKey | RCINICONZNJXQF-MZXODVADSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.5 | Rotatable Bond Count | 14 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 14 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.